AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Emergent BioSolutions Inc. Director's Dealing 2014

Apr 17, 2014

32870_dirs_2014-04-17_4a903a9c-492c-4ee4-925c-4abb3a8ead56.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Emergent BioSolutions Inc. (EBS)
CIK: 0001367644
Period of Report: 2014-04-15

Reporting Person: Kramer Robert (CFO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2014-04-15	Common Stock	S	2500	$24.00	Disposed	109872	Direct
2014-04-16	Common Stock	S	47689	$24.36	Disposed	62183	Direct

Footnotes

F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Mr. Kramer. Mr. Kramer's direct holdings include restricted stock units granted under the Amended and Restated Emergent BioSolutions Inc. 2006 Stock Incentive Plan as well as shares acquired through private placement.

F2: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $24.00 to $24.68, inclusive